Marjan Rouzbahman
Papers
1
Total Citations
224
H-Index
1
About
Dr. Marjan Rouzbahman is a leading pathologist whose research focuses on gynecologic cancers, particularly endometrial and ovarian malignancies, with a strong emphasis on improving surgical staging and patient outcomes. Her most impactful work challenges conventional approaches to endometrial cancer management. In a landmark 2020 study cited over 224 times, she investigated whether sentinel lymph node biopsy (SLNB) using indocyanine green could replace full lymphadenectomy for intermediate- and high-grade endometrial cancer staging. This work demonstrated that SLNB offers comparable diagnostic accuracy with significantly reduced morbidity, providing crucial evidence for a paradigm shift in surgical practice. Beyond this, Dr. Rouzbahman has made substantial contributions to understanding the molecular pathology of ovarian and uterine tumors, helping to refine risk stratification and treatment strategies. Her research consistently bridges pathology and clinical oncology, directly influencing surgical decision-making and patient care. With a citation impact reflecting the clinical urgency of her findings, Dr. Rouzbahman is recognized as a key voice in gynecologic pathology, advancing less invasive, more precise staging techniques that improve quality of life for women with cancer.
Research Focus
Key Achievements
Top Papers
- 1